Cargando…

Examination of Resource Use and Clinical Interventions Associated With Chronic Kidney Disease in a Managed Care Population

BACKGROUND: The management of chronic kidney disease (CKD) is multifaceted, including monitoring, early diagnosis, and treatment of comorbidities such as diabetes, hypoalbuminemia, and anemia, and initiating timely procedures in preparation for dialysis such as vascular access placement. Presumably,...

Descripción completa

Detalles Bibliográficos
Autores principales: London, Roger, Sols, Amy, Goldberg, George A., Wade, Sally, Chan, Wing W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437269/
https://www.ncbi.nlm.nih.gov/pubmed/14613468
http://dx.doi.org/10.18553/jmcp.2003.9.3.248
_version_ 1785092479788253184
author London, Roger
Sols, Amy
Goldberg, George A.
Wade, Sally
Chan, Wing W.
author_facet London, Roger
Sols, Amy
Goldberg, George A.
Wade, Sally
Chan, Wing W.
author_sort London, Roger
collection PubMed
description BACKGROUND: The management of chronic kidney disease (CKD) is multifaceted, including monitoring, early diagnosis, and treatment of comorbidities such as diabetes, hypoalbuminemia, and anemia, and initiating timely procedures in preparation for dialysis such as vascular access placement. Presumably, optimal care provided to patients during the predialysis phase will produce a significant impact on morbidity and mortality outcomes. OBJECTIVES: A retrospective analysis was conducted to assess specific factors that may be associated with optimal quality of care for CKD patients during the predialysis phase. METHODS: Health care resource utilization and the occurrence of interventions associated with optimal predialysis care were evaluated with claims data. Predialysis erythropoietin (EPO) therapy, nephrology referrals, and nutritional supplement administration were all examined during the 12 months prior to dialysis. RESULTS: Medical and pharmacy claims from a managed care database were analyzed for 1,936 incident dialysis patients. Of these, 48.7% did not have any interventions associated with optimal care. Only a minority of patients received prescription iron preparations (6.8%), vitamin D (4.0%), and phosphate binders (7.7%). A total of 20.8% patients had a vascular access placement, and 29.8% were in the care of a nephrologist during this same time period. Only 10.5% received predialysis EPO, yet more than 40% were diagnosed with anemia. Of the EPO users, however, 72.4% were also receiving other interventions to appropriately manage CKD. CONCLUSIONS: These claims-documented results suggest that the lack of EPO use in predialysis patients in a managed care plan may predict overall suboptimal treatment of these patients. There is an apparent need for the proactive management of CKD in a managed care plan to potentially redistribute or reduce health care resource utilization while improving patient outcomes.
format Online
Article
Text
id pubmed-10437269
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-104372692023-08-21 Examination of Resource Use and Clinical Interventions Associated With Chronic Kidney Disease in a Managed Care Population London, Roger Sols, Amy Goldberg, George A. Wade, Sally Chan, Wing W. J Manag Care Pharm Research BACKGROUND: The management of chronic kidney disease (CKD) is multifaceted, including monitoring, early diagnosis, and treatment of comorbidities such as diabetes, hypoalbuminemia, and anemia, and initiating timely procedures in preparation for dialysis such as vascular access placement. Presumably, optimal care provided to patients during the predialysis phase will produce a significant impact on morbidity and mortality outcomes. OBJECTIVES: A retrospective analysis was conducted to assess specific factors that may be associated with optimal quality of care for CKD patients during the predialysis phase. METHODS: Health care resource utilization and the occurrence of interventions associated with optimal predialysis care were evaluated with claims data. Predialysis erythropoietin (EPO) therapy, nephrology referrals, and nutritional supplement administration were all examined during the 12 months prior to dialysis. RESULTS: Medical and pharmacy claims from a managed care database were analyzed for 1,936 incident dialysis patients. Of these, 48.7% did not have any interventions associated with optimal care. Only a minority of patients received prescription iron preparations (6.8%), vitamin D (4.0%), and phosphate binders (7.7%). A total of 20.8% patients had a vascular access placement, and 29.8% were in the care of a nephrologist during this same time period. Only 10.5% received predialysis EPO, yet more than 40% were diagnosed with anemia. Of the EPO users, however, 72.4% were also receiving other interventions to appropriately manage CKD. CONCLUSIONS: These claims-documented results suggest that the lack of EPO use in predialysis patients in a managed care plan may predict overall suboptimal treatment of these patients. There is an apparent need for the proactive management of CKD in a managed care plan to potentially redistribute or reduce health care resource utilization while improving patient outcomes. Academy of Managed Care Pharmacy 2003-05 /pmc/articles/PMC10437269/ /pubmed/14613468 http://dx.doi.org/10.18553/jmcp.2003.9.3.248 Text en Copyright © 2003, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Research
London, Roger
Sols, Amy
Goldberg, George A.
Wade, Sally
Chan, Wing W.
Examination of Resource Use and Clinical Interventions Associated With Chronic Kidney Disease in a Managed Care Population
title Examination of Resource Use and Clinical Interventions Associated With Chronic Kidney Disease in a Managed Care Population
title_full Examination of Resource Use and Clinical Interventions Associated With Chronic Kidney Disease in a Managed Care Population
title_fullStr Examination of Resource Use and Clinical Interventions Associated With Chronic Kidney Disease in a Managed Care Population
title_full_unstemmed Examination of Resource Use and Clinical Interventions Associated With Chronic Kidney Disease in a Managed Care Population
title_short Examination of Resource Use and Clinical Interventions Associated With Chronic Kidney Disease in a Managed Care Population
title_sort examination of resource use and clinical interventions associated with chronic kidney disease in a managed care population
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437269/
https://www.ncbi.nlm.nih.gov/pubmed/14613468
http://dx.doi.org/10.18553/jmcp.2003.9.3.248
work_keys_str_mv AT londonroger examinationofresourceuseandclinicalinterventionsassociatedwithchronickidneydiseaseinamanagedcarepopulation
AT solsamy examinationofresourceuseandclinicalinterventionsassociatedwithchronickidneydiseaseinamanagedcarepopulation
AT goldberggeorgea examinationofresourceuseandclinicalinterventionsassociatedwithchronickidneydiseaseinamanagedcarepopulation
AT wadesally examinationofresourceuseandclinicalinterventionsassociatedwithchronickidneydiseaseinamanagedcarepopulation
AT chanwingw examinationofresourceuseandclinicalinterventionsassociatedwithchronickidneydiseaseinamanagedcarepopulation